Hunan Warrant Pharmaceutical Co., Ltd. Class ASSE: 688799

"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

Sep 9, 2026 · Issued by Hunan Warrant Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 9, 2026

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Hunan Warrant Pharmaceutical Co., Ltd. Class A

"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Voluntary Disclosure of the Subsidiary's Obtaining of the Approval Notice for Its API Marketing ApplicationSep 3
"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Voluntary Disclosure of Obtaining Drug Registration CertificateSep 1
"Hunan Warrant Pharmaceutical Co., Ltd."Indicative Announcement on Shareholding Reduction Plan of Controlling Shareholder and Proposed Change of Shareholding Form by the Controlling Shareholder's PartnerAug 26
"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Increasing Cash Management Limit for Temporarily Idle Self-owned FundsAug 25

All Hunan Warrant Pharmaceutical Co., Ltd. Class A news releases